'Renal denervation' diaporamas de présentation

665 views • 49 slides

Giuliano Tocci, MD, PhD, ESH Hypertension Specialist

479 views • 32 slides

Symplicity HTN-1: 36-mo Follow-up Sustained Reductions in BP

Thank you for taking the preassessment. (Note: the questions were developed by an independent consulting group with expertise in assessing the effectiveness of medical education.) To assess learning, these questions will be repeated at the end of the activity.

395 views • 28 slides

Renal Denerva syon

409 views • 26 slides

Hypertension and The Kidney Update: Clinical Trials

Hypertension and The Kidney Update: Clinical Trials. Paul J. Scheel, Jr., M.D. Director, Division of Nephrology The Johns Hopkins University School of Medicine. Primary Diagnosis in Patients With Kidney Disease. Patient Primary Diagnosis. Other. Glomerulonephritis. Diabetes. 45%.

394 views • 24 slides

Stefan Bertog, Laura Vaskelyte, Ilona Hofmann, Sameer Gafoor, Simon Lam, Horst Sievert

CSI-TRENDS Taipei 2013. The Importance of the Sympathetic Nervous System in Hypertension: Human data Including early Human Experience with renal Denervation (MSNA, NE spillover, renin etc.). Stefan Bertog, Laura Vaskelyte, Ilona Hofmann, Sameer Gafoor, Simon Lam, Horst Sievert

437 views • 24 slides

Hypertension and The Kidney Update: Clinical Trials

Hypertension and The Kidney Update: Clinical Trials. Paul J. Scheel, Jr., M.D. Director, Division of Nephrology The Johns Hopkins University School of Medicine. Primary Diagnosis in Patients With Kidney Disease. Patient Primary Diagnosis. Other. Glomerulonephritis. Diabetes. 45%.

382 views • 24 slides

K. Dimitriadis, PhD, FESC Consultant Cardiologist First Cardiology Clinic, University of Athens,

241 views • 24 slides

Philipp Lurz , Karl Fengler, Karl-Philipp Rommel, Stephan Blazek,

A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients with Resistant Hypertension (RADIOSOUND-HTN). Philipp Lurz , Karl Fengler, Karl-Philipp Rommel, Stephan Blazek, Christian Besler, Philipp Hartung, Maximilian von Roeder, MD; Martin Petzold,

220 views • 21 slides

Economic Burden of Hypertension

Economic Burden of Hypertension. Cost-effectiveness Analysis Therapy Effectiveness and Cost Compared With Status Quo. Renal Denervation Reduces Blood Pressure. Renal Denervation Health Economic Model. Projected 10-y Relative Reductions in Clinical Events (by age and pretreatment SBP).

307 views • 12 slides

Renal Denervation Devices Market Opportunity Analysis, 2018-2026

Renal denervation is a catheter-based minimally invasive procedure. It is a therapy carried out by radiofrequency or ultrasound ablation for uncontrolled hypertension. Renal denervation is performed through endovascular catheter-based procedure to treat hypertension, which is beyond medication control. The procedure consists of a catheter that emits radiofrequency energy across multiple electrodes.

34 views • 3 slides

Renal Denervation Market Research Report - Global Forecast till 2023

Renal Denervation Market Growth Research Report - Global Forecast till 2023

33 views • 3 slides

Renal Denervation Market Research Report

Renal Denervation Market Research Report - Global Forecast Till 2023

31 views • 3 slides

Renal Denervation Market Research Report - Global Forecast till 2023

Global Renal Denervation Market Research Report: by Product (Symplicity, Vessix (V2), EnligHTN, Paradise, Iberis, Others), by Technology (Radiofrequency, Ultrasound, Micro-infusion, and Others), by End-user (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Region - Forecast To 2023

22 views • 2 slides

Renal Denervation Industry Research Report - Global Forecast till 2023

Renal Denervation Industry Research Report - Global Forecast till 2023

21 views • 2 slides